Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study
Introduction The use of immune checkpoint inhibitors (ICIs) is rapidly expanding in cancer treatment. ICIs have a unique safety profile, characterised by immune-related adverse events (irAEs). The safety profile of ICIs lacks patient experience and perspectives. This study primarily aims to obtain a...
Main Authors: | Takuhiro Yamaguchi, Tempei Miyaji, Takashi Kawaguchi, Kanako Azuma, Taiki Hirata, Ayako Torii, Hiroaki Usui, Soan Kim, Tatsuya Hayama, Daisuke Hirate, Yosuke Kawahara, Yuki Kumihashi, Tomomi Chisaka, Tetsuya Wako, Akinobu Yoshimura |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/11/e073724.full |
Similar Items
-
The development and analysis of a Japanese modern comprehensive clinical data management training program
by: Takuhiro Yamaguchi, et al.
Published: (2024-03-01) -
Adherence to anti-retroviral therapy, decisional conflicts, and health-related quality of life among treatment-naïve individuals living with HIV: a DEARS-J observational study
by: Yusuke Sekine, et al.
Published: (2023-03-01) -
How to select and understand guidelines for patient-reported outcomes: a scoping review of existing guidance
by: Takako Kaneyasu, et al.
Published: (2024-03-01) -
Protocol for the ASTRO study (SSOP-01): a multicentre prospective cohort study investigating adverse events based on electronic patient-reported outcomes in patients with breast cancer after adjuvant chemotherapy
by: Takuhiro Yamaguchi, et al.
Published: (2023-09-01) -
Emerging Immune-Monitoring System for Immune Checkpoint Inhibitors
by: Kazuyuki Hamada, et al.
Published: (2022-08-01)